Entera Bio (ENTX) Accounts Payables (2017 - 2026)
Entera Bio (ENTX) recorded quarterly Accounts Payables of $274000.0 in Q1 2026, down 38.84% on a QoQ basis from $448000.0 in Q4 2025, and up 104.48% year-over-year from $134000.0 in Q1 2025.
Entera Bio (ENTX) Accounts Payables (2017 - 2026) Analysis & Trends
Entera Bio has disclosed Accounts Payables across 9 years of filings, most recently posting $274000.0 for Q1 2026.
- Quarterly Accounts Payables rose 104.48% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274000.0 (up 104.48% YoY) and the FY2025 annual result came in at $448000.0, up 239.39% from the prior year.
- Accounts Payables slipped to $274000.0 in Q1 2026, from $448000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $564000.0 in Q3 2023 and troughed at $17000.0 in Q4 2022.
- A 5-year average of $216529.4 and a median of $184000.0 in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables plunged 89.76% — and 2025, when it jumped 455.07%.
- Tracing ENTX's Accounts Payables over 5 years: stood at $17000.0 in 2022, then jumped by 388.24% to $83000.0 in 2023, then soared by 59.04% to $132000.0 in 2024, then surged by 239.39% to $448000.0 in 2025, then slumped by 38.84% to $274000.0 in 2026.
- Business Quant data shows ENTX's Accounts Payables at $274000.0 in Q1 2026, $448000.0 in Q4 2025, and $216000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 34.55 Mn |
| 10 | Entera Bio | 57.79 Mn | 53.65 Mn | - | 274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 216,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 413,000.00 |
| Jun 30, 2022 | 109,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Dec 31, 2020 | 164,000.00 |
| Dec 31, 2018 | 1.09 Mn |